Biotechnology, Breakthrough Drugs, and Health Care Reform [electronic resource] : Lessons from the NIH-University-Industry Relationship

Corporate Author: Library of Congress. Congressional Research Service
Published: [Place of publication not identified] : [publisher not identified], 1994.
Physical Description: 35 pages : digital, PDF file

Access Online

Electronic resource (PDF)

Availability

Finding items...

Summary

Examines the possible effects of price control strategies on the biotechnology community; its pursuit of research, development, and commercialization; and the ultimate availability of new, genetically-engineered therapeutics and diagnostics. Analyzes the interaction of the National Institutes of Health (NIH) and the pharmaceutical industry.

Subject(s)

Related Titles

ProQuest U.S. Congressional Research Digital Collection

Note

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
CRS Report.
AVAILABLE ONLINE TO AUTHORIZED PSU USERS.

Technical Details

System requirements: PDF reader software.

View MARC record | catkey: 10073537